Vita-Assay™ is a cell culture plate specially formulated using our proprietary cell adhesion matrices (CAM) to capture and preserve viable rare circulating cells after removal of red blood cells from blood or tissue fluids. Vita-Assay™ is particularly useful for the isolation of rare circulating cells that involves further culturing for propagation of the rare cells. Similar to Vita-Cap™, Vita-Assay™ enables molecular characterization of the enriched cells using analytic tools including immunocytochemistry, immunofluorescence, flow cytometry, FISH, cytogenetics, quantitative RT-PCR, DNA microarray, proteomics and genomics. Vita-Assay™ is offered in a 16-well glass slide format (Vita-Assay™ A16)..

Vita-Cap™ is a series of modified blood collection tubes specially formulated using our proprietary cell adhesion matrices (CAM) to capture and preserve viable rare circulating cells in a single step from blood or tissue fluids. Vita-Cap™ decreases the manual labor required to process a blood sample while simultaneously increasing the efficiency of rare cell isolation. As it is primarily formulated in standard blood collection tubes and flasks, this device will simplify blood collection and sample testing while preserving the viability of rare circulating cells.

Vitatex has a series of monoclonal antibodies that direct against tumor cell surface antigens involved in the development of human malignant tumors and metastasis. These monoclonal antibodies are useful in cancer research and in the development of cancer diagnostic and therapeutic targets.

Vitatex is an early-stage biotech company, focused on commercializing proprietary rare cell-enrichment research and diagnostic products. We believe that our products can provide significant R&D and clinical benefits. Our products help researchers obtain target cells, genes and gene products that have great promise to develop new diagnostic and therapeutic products.

Our technologies, which we brand as Vita-Assays™ and Vita-Cap™ and associated reagent kits, can isolate and characterize viable tumor, stem and progenitor cells from a tube of blood. Our technologies target functional characteristics of circulating tumor cells, cancer progenitor cells, and circulating endothelial cells based on their aggressive nature.

More about Vitatex...